In Canada, the forecasted mortality rate for Parkinson's Disease among women shows a gradual increase from 5.4 per 100,000 in 2024, stabilizing at 5.5 in the subsequent years until 2027, and then slightly rising to 5.6 in 2028. This indicates a 0.2% year-on-year increase from 2024 to 2025, with stability thereafter and a slight uptick of 1.8% by 2028 compared to 2024. The compound annual growth rate (CAGR) over this period is minimal, highlighting a modest upward trend.

Key trends to monitor include:

The impact of aging populations on disease prevalence and related mortality rates.
Advancements in medical research and treatment options potentially influencing future mortality rates.
Healthcare policy changes affecting early detection and disease management strategies.